Luiz E. Bertassoni

Dr. Luiz E. Bertassoni is Professor at the Division of Oncological Sciences at Oregon Health & Science University's Knight Cancer Institute, where he serves as founding director of the Knight Cancer Precision Biofabrication Hub and co-section head for Discovery and Translational Oncology. He holds joint appointments in the Department of Biomedical Engineering, Cancer Early Detection Advanced Research (CEDAR) center, and OHSU School of Dentistry.

Education

• D.D.S. (2007)
• Ph.D. in Biomaterials, University of Sydney (2012)

Postdoctoral training:

• Harvard Medical School (2012-2013)
• Brigham and Women's Hospital (2012-2013)
• University of California, San Francisco (2007-2009)

Research Focus

Dr. Bertassoni leads multidisciplinary research in biofabrication technologies including 3D bioprinting, organs-on-chips, and regenerative medicine. His laboratory develops innovative approaches for creating vascularized tissue constructs, cancer models, and biomimetic materials with applications in precision oncology and tissue regeneration.

Publication Trends

Recent work demonstrates strong focus on vascularization techniques, advanced bioprinting methodologies, and microphysiological systems for bone and vascular tissue engineering. Publications consistently integrate nanotechnology, biomimetic design principles, and translational applications in cancer research.

Honors

• Medical Research Foundation New Investigator Award
• Silver Family Faculty Innovation Award
• Recipient of over 30 national/international research awards

Leadership

Founded the Knight Cancer Precision Biofabrication Hub and co-founded two biotechnology companies. Leads multidisciplinary team developing biofabrication platforms for cancer research and regenerative applications. Editorial board member for 10 journals and reviewer for 60+ peer-reviewed publications.